Published in J Bacteriol on February 24, 2012
Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. MBio (2013) 2.20
Restricted gene flow among hospital subpopulations of Enterococcus faecium. MBio (2012) 1.92
Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era. Curr Opin Microbiol (2013) 1.57
Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes. BMC Microbiol (2012) 1.43
Genomic insights to control the emergence of vancomycin-resistant enterococci. MBio (2013) 1.37
Genome-wide identification of ampicillin resistance determinants in Enterococcus faecium. PLoS Genet (2012) 1.17
Large chromosomal rearrangements during a long-term evolution experiment with Escherichia coli. MBio (2014) 1.14
Recent recombination events in the core genome are associated with adaptive evolution in Enterococcus faecium. Genome Biol Evol (2013) 1.04
Core Genome Multilocus Sequence Typing Scheme for High- Resolution Typing of Enterococcus faecium. J Clin Microbiol (2015) 0.99
Comparative analysis of the complete genome of an epidemic hospital sequence type 203 clone of vancomycin-resistant Enterococcus faecium. BMC Genomics (2013) 0.98
Nonclinical and clinical Enterococcus faecium strains, but not Enterococcus faecalis strains, have distinct structural and functional genomic features. Appl Environ Microbiol (2013) 0.86
Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium. Antimicrob Agents Chemother (2014) 0.86
Optimizing hybrid assembly of next-generation sequence data from Enterococcus faecium: a microbe with highly divergent genome. BMC Syst Biol (2012) 0.86
Safety of the surrogate microorganism Enterococcus faecium NRRL B-2354 for use in thermal process validation. Appl Environ Microbiol (2014) 0.84
Plasmids from Food Lactic Acid Bacteria: Diversity, Similarity, and New Developments. Int J Mol Sci (2015) 0.81
Complete genome sequence of Enterococcus mundtii QU 25, an efficient L-(+)-lactic acid-producing bacterium. DNA Res (2014) 0.81
ICESluvan, a 94-kilobase mosaic integrative conjugative element conferring interspecies transfer of VanB-type glycopeptide resistance, a novel bacitracin resistance locus, and a toxin-antitoxin stabilization system. J Bacteriol (2013) 0.81
Evolutionary origins of the emergent ST796 clone of vancomycin resistant Enterococcus faecium. PeerJ (2017) 0.80
Population structure and acquisition of the vanB resistance determinant in German clinical isolates of Enterococcus faecium ST192. Sci Rep (2016) 0.79
A LacI-family regulator activates maltodextrin metabolism of Enterococcus faecium. PLoS One (2013) 0.79
Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility. Antimicrob Agents Chemother (2014) 0.78
Distinct SagA from Hospital-Associated Clade A1 Enterococcus faecium Strains Contributes to Biofilm Formation. Appl Environ Microbiol (2015) 0.77
Investigating the mobilome in clinically important lineages of Enterococcus faecium and Enterococcus faecalis. BMC Genomics (2015) 0.76
A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium. J Biol Chem (2015) 0.76
Impact of Antibiotic Use on the Evolution of Enterococcus faecium. J Infect Dis (2015) 0.75
Histopathological changes induced in an animal model by potentially pathogenic Enterococcus faecalis strains recovered from ready-to-eat food outlets in Osun State, Nigeria. Infect Drug Resist (2015) 0.75
Genomic Features and Niche-Adaptation of Enterococcus faecium Strains from Korean Soybean-Fermented Foods. PLoS One (2016) 0.75
Subinhibitory Concentrations of Ciprofloxacin Enhance Antimicrobial Resistance and Pathogenicity of Enterococcus faecium. Antimicrob Agents Chemother (2017) 0.75
Genomic confirmation of vancomycin-resistant Enterococcus transmission from deceased donor to liver transplant recipient. PLoS One (2017) 0.75
Nonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens. Nat Prod Rep (2017) 0.75
Application of phylogenetic networks in evolutionary studies. Mol Biol Evol (2005) 31.72
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
PHAST: a fast phage search tool. Nucleic Acids Res (2011) 19.09
CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res (2007) 15.56
A new DNA sequence assembly program. Nucleic Acids Res (1995) 12.03
SHRiMP: accurate mapping of short color-space reads. PLoS Comput Biol (2009) 11.24
CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea. Nat Rev Microbiol (2008) 8.91
BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics (2011) 7.27
Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol (2002) 5.09
Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science (2003) 4.55
Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data. Bioinformatics (2011) 4.31
Interpolated variable order motifs for identification of horizontally acquired DNA: revisiting the Salmonella pathogenicity islands. Bioinformatics (2006) 4.27
Easyfig: a genome comparison visualizer. Bioinformatics (2011) 4.23
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci U S A (2004) 3.52
Glycopeptide resistance in enterococci. Trends Microbiol (1996) 3.42
Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis (2005) 3.32
The ecology, epidemiology and virulence of Enterococcus. Microbiology (2009) 3.05
Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol (1998) 2.72
Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis (2001) 2.46
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol (1998) 2.41
Genetic diversity among Enterococcus faecalis. PLoS One (2007) 2.32
Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol (2008) 2.13
Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog (2007) 2.10
Mutational bias suggests that replication termination occurs near the dif site, not at Ter sites. Mol Microbiol (2007) 2.06
Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island. BMC Genomics (2010) 1.90
A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol (2004) 1.90
Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol (2003) 1.85
Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci. Proc Natl Acad Sci U S A (2006) 1.68
High-quality draft genome sequences of 28 Enterococcus sp. isolates. J Bacteriol (2010) 1.67
Construction of improved temperature-sensitive and mobilizable vectors and their use for constructing mutations in the adhesin-encoding acm gene of poorly transformable clinical Enterococcus faecium strains. Appl Environ Microbiol (2006) 1.59
Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis (2007) 1.55
Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr Protein Pept Sci (2005) 1.54
Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium. PLoS One (2012) 1.54
Cotransfer of antibiotic resistance genes and a hylEfm-containing virulence plasmid in Enterococcus faecium. Antimicrob Agents Chemother (2009) 1.51
A classification system for plasmids from enterococci and other Gram-positive bacteria. J Microbiol Methods (2009) 1.48
Roles of antibodies and complement in phagocytic killing of enterococci. Infect Immun (1994) 1.46
Emergence of clonal complex 17 Enterococcus faecium in The Netherlands. J Clin Microbiol (2007) 1.45
Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. Antimicrob Agents Chemother (2006) 1.43
Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother (1997) 1.37
Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model. J Infect Dis (2009) 1.30
A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203. J Infect Dis (2010) 1.27
Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur J Clin Microbiol Infect Dis (2000) 1.21
Comparative genomics of Enterococcus faecalis from healthy Norwegian infants. BMC Genomics (2009) 1.19
The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS One (2011) 1.16
Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother (2003) 1.13
Copper resistance in Enterococcus faecium, mediated by the tcrB gene, is selected by supplementation of pig feed with copper sulfate. Appl Environ Microbiol (2006) 1.08
Genome-based insights into the evolution of enterococci. Clin Microbiol Infect (2010) 1.05
Virulence and antimicrobial resistance in clinical Enterococcus faecium. Int J Antimicrob Agents (2008) 1.00
Vancomycin resistance: status quo and quo vadis. Eur J Clin Microbiol Infect Dis (1999) 1.00
Transposon characterization of vancomycin-resistant Enterococcus faecium (VREF) and dissemination of resistance associated with transferable plasmids. J Antimicrob Chemother (2007) 0.98
Variant esp gene in vancomycin-sensitive Enterococcus faecium. Lancet (2001) 0.96
Presence of pRI1: a small cryptic mobilizable plasmid isolated from Enterococcus faecium of human and animal origin. Curr Microbiol (2008) 0.88
Fitness effects of replichore imbalance in Salmonella enterica. J Bacteriol (2010) 0.86
Enterococcal surface protein Esp does not facilitate intestinal colonization or translocation of Enterococcus faecalis in clindamycin-treated mice. FEMS Microbiol Lett (2005) 0.83
Rapid detection of antibacterial resistance in emerging Gram-positive cocci. J Hosp Infect (2005) 0.83
Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice. BMC Microbiol (2009) 0.80
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services. Med J Aust (2013) 4.93
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev (2010) 4.76
Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis (2004) 4.09
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis (2004) 4.06
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis (2011) 3.98
A microRNA catalog of the developing chicken embryo identified by a deep sequencing approach. Genome Res (2008) 3.74
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci U S A (2004) 3.52
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res (2007) 3.45
Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res (2008) 3.26
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother (2010) 3.03
Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis (2010) 2.98
Pesticide exposure and risk for Parkinson's disease. Ann Neurol (2006) 2.89
Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol (2007) 2.75
Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci U S A (2006) 2.71
Use of ibuprofen and risk of Parkinson disease. Neurology (2011) 2.70
Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke (2005) 2.63
2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis (2010) 2.60
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis (2007) 2.56
Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2006) 2.43
Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One (2008) 2.35
Mycobacterium ulcerans disease. Bull World Health Organ (2005) 2.30
Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust (2005) 2.29
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet (2011) 2.28
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24
NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog (2008) 2.23
Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust (2009) 2.16
Concurrent analysis of nose and groin swab specimens by the IDI-MRSA PCR assay is comparable to analysis by individual-specimen PCR and routine culture assays for detection of colonization by methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 2.16
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog (2011) 2.15
Methicillin-resistant Staphylococcus aureus in hospitals: time for a culture change. Med J Aust (2007) 2.06
Conundrums in community-acquired pneumonia. Med J Aust (2006) 2.04
Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis (2011) 2.00
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology (2007) 1.97
Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev (2009) 1.91
Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun (2002) 1.89
Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother (2008) 1.89
Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol (2009) 1.87
Diabetes and risk of Parkinson's disease. Diabetes Care (2011) 1.80
A major role for mammals in the ecology of Mycobacterium ulcerans. PLoS Negl Trop Dis (2010) 1.80
Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J Infect Dis (2012) 1.78
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol (2009) 1.77
Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog (2010) 1.74
Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory. J Clin Microbiol (2013) 1.71
Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis (2010) 1.70
Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69
Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog (2012) 1.68
Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis (2009) 1.67
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet (2013) 1.67
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J Antimicrob Chemother (2008) 1.66
Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect Immun (2006) 1.62
Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr (2002) 1.61
The outdoor air pollution and brain health workshop. Neurotoxicology (2012) 1.60
Both low and high temperature may increase the risk of stroke mortality. Neurology (2013) 1.59
Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis (2005) 1.59
On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. BMC Genomics (2012) 1.58
Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr (2007) 1.57
First case of Mycobacterium ulcerans disease (Bairnsdale or Buruli ulcer) acquired in New South Wales. Med J Aust (2007) 1.56
Outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south-eastern Australian case series. Med J Aust (2007) 1.56
Conservation of the S10-spc-alpha locus within otherwise highly plastic genomes provides phylogenetic insight into the genus Leptospira. PLoS One (2008) 1.55
Multivitamin use and telomere length in women. Am J Clin Nutr (2009) 1.54
Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun (2002) 1.54
Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene (2004) 1.54
Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis (2007) 1.53
Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. PLoS One (2011) 1.53